These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 19621693

  • 1. Factors influencing the indocyanine green (ICG) test: additional impact of acute cholestasis.
    Stockmann M, Malinowski M, Lock JF, Seehofer D, Neuhaus P.
    Hepatogastroenterology; 2009; 56(91-92):734-8. PubMed ID: 19621693
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ.
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À, Mas A, Fernández J, García-Valdecasas JC.
    Transplant Proc; 2012 Feb; 44(6):1539-41. PubMed ID: 22841207
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M.
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
    Lao XM, Zhang YQ, Guan YX, Guo RP, Lin XJ, Yuan YF, Li JQ, Li GH.
    Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
    [Abstract] [Full Text] [Related]

  • 13. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
    Scheingraber S, Richter S, Igna D, Girndt M, Flesch S, Kleinschmidt S, Schilling MK.
    Clin Transplant; 2007 Oct; 21(6):689-95. PubMed ID: 17988260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT, Memiş D, Kargi M, Sut N.
    J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
    [Abstract] [Full Text] [Related]

  • 19. Relation of biliary bile acid output to hepatic adenosine triphosphate level and biliary indocyanine green excretion in humans.
    Chijiiwa K, Mizuta A, Ueda J, Takamatsu Y, Nakamura K, Watanabe M, Kuroki S, Tanaka M.
    World J Surg; 2002 Apr; 26(4):457-61. PubMed ID: 11910480
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.